Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Not 'off to the races': UK science adviser urges caution in easing COVID lockdown

FILE PHOTO: Chief Scientific Adviser Sir Patrick Vallance attends a news conference in response to the ongoing situation with the coronavirus disease (COVID-19) pandemic, inside 10 Downing Street, London, Britain, January 5, 2021. REUTERS/Hannah McKay/Pool

British Prime Minister Boris Johnson must only ease lockdown in England with 4 to 5 weeks between stages so that the impact of the moves can be assessed and relaxation can be paused if needed, his top science adviser Patrick Vallance said on Monday.

Vallance said that though there was encouraging evidence from Britain's vaccine rollout, it could not be "off to the races" as Johnson outlined plans to ease restrictions in England.

"We are in a not very good position, which is getting better," Vallance told reporters.

"The message that comes out of all of the modelling is... get (infection) numbers down before you start releasing, go slowly, (and) go in blocks that you can measure the effect of after four or five weeks."

Vallance said that even achieving good coverage with highly effective vaccines, a large portion of the population would remain unprotected, which underpinned the cautious approach to ending lockdown.

Government scientific advisers warned that very fast unlocking by late April would lead to a new large wave of infections, and have recommended a staggered approach.

"It would take a minimum of three weeks after lifting one set of restrictions to determine whether it is safe to take the next step," said a summary of modelling advice published on Monday by the Government Office for Science.

Data from Scotland and Public Health England suggested that the vaccine rollout in Britain is having an effect in reducing severe disease and deaths.

But Vallance said that it would be a mistake to become overly optimistic.

"The right information is not that vaccines are 100% effective and it's all off to the races. It's absolutely not that," he said.

"There is still a risk. We've got high numbers, we need to go cautiously. We need to unlock and measure."

(Reporting by Alistair Smout and Kate Kelland; editing by Guy Faulconbridge)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.